Vig01 (Vig01)
Chemical structure of Vigabatrin, showing its molecular arrangement including an aldehyde group, an amine group, and a carboxylic acid group.*
Vigabatrin Powder, For Solution
Product Images NDC 67877-674
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 67877-674). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Vig02 (Vig02)
A line graph titled 'Percent Reduction from Baseline in Seizure Frequency' showing four curves representing placebo, 1g/day, 3g/day, and 6g/day doses of Vigabatrin (VGB). The y-axis measures percent reduction in seizure frequency ranging from -100 to 100, and the x-axis represents the percentage of patients from 100% to 0%. The graph illustrates varying levels of improvement in seizure frequency reduction across the different dosing groups, with higher doses generally showing greater improvement.*
Vig03 (Vig03)
A cumulative distribution plot titled 'Percent Reduction from Baseline in Seizure Frequency,' comparing placebo and 3 g/day VGB treatment groups. The x-axis represents the percentage of patients, and the y-axis shows the percent reduction in seizure frequency, with annotations for improvement and worsening. The lines depict seizure frequency reduction for each group.*
Vig04 (Vig04)
Vigabatrin for Oral Solution, USP 500 mg powder for solution in a single packet from Ascend Laboratories, LLC. The image shows the packet alongside a glass of water, an empty clear mug with a spoon, a syringe, and scissors, suggesting preparation for oral administration.*
Vig05 (Vig05)
An instructional labeled diagram of a plastic oral syringe used for dosing liquid medication. The image highlights parts of the syringe including the tip, barrel with dosage indicators, edge of the plunger, and the plunger itself. The syringe is clear with black dosage markings.*
Vig06 (Vig06)
An instructional illustration showing a hand holding a VIGABATRIN 50 mg/mL powder for solution oral dose packet above a clear glass mug, indicating the preparation of the oral solution by dissolving the powder in water or another liquid.*
Vig07 (Vig07)
Illustration showing two clear glass measuring cups with handles placed side by side on a flat surface. The cup on the left is empty, while the cup on the right contains a clear liquid filled to about one-third of its height. This image may relate to measuring or preparing oral liquid medication.*
Vig08 (Vig08)
An instructional image showing a person's hands mixing a powdered medication from a tube into a clear glass of water, demonstrating preparation for oral administration. The image is related to the oral powder for solution dosage form of Vigabatrin.*
Vig09 (Vig09)
A black and white photo showing a hand holding a dosing syringe, marked with measurement lines up to 10 mL, typically used for oral liquid medication administration.*
Vig10 (Vig10)
Illustration showing a hand holding a graduated oral syringe labeled with milliliter measurements, highlighting the 10 mL line. The syringe is used for measuring doses of liquid medication like VIGABATRIN powder for solution, 50 mg/mL.*
Vig11 (Vig11)
An illustration showing a hand holding a dosing syringe being placed into a transparent glass cup. The syringe has visible measurement markings for accurate liquid measurement, demonstrating a method for preparing an oral liquid medication dose.*
Vig12 (Vig12)
A black-and-white image showing a hand holding a spoon inside a transparent glass cup filled with clear liquid. This image appears to illustrate the process of stirring a solution, possibly related to preparing an oral powder medication like Vigabatrin.*
Vig13 (Vig13)
Illustration showing a person stirring a solution in a tall transparent glass cup with a marked measuring stirrer, likely demonstrating the preparation of an oral solution. The image is in black and white and focuses on the hands and the glass.*
Vig14 (Vig14)
Black and white photo showing a hand holding an oral dosing syringe filled with liquid. The syringe is marked with volume measurements up to 10 mL, used for measuring and administering oral medication solutions.*
Vig15 (Vig15)
Black and white photo showing a child receiving an oral medication from a syringe-like dispenser held by an adult. The child has their mouth open to accept the liquid dose.*
Vig16 (Vig16)
Vigabatrin 500 mg powder for oral solution packet label by Ascend Laboratories, LLC. The front displays the drug name, strength, dosage form, and a note to dispense the enclosed medication guide. The back includes usage directions, manufacturer information, a barcode, and storage instructions.*
Vig17 (Vig17)
Carton packaging label for Vigabatrin for Oral Solution, USP 500 mg powder for solution. The label shows the product name, strength (500 mg), and indicates it is for oral use. It includes instructions to dispense the enclosed medication guide with each prescription. The label specifies Rx only and contains 50 packets. It is manufactured by Alkem Laboratories Ltd., India, and distributed by Ascend Laboratories, LLC, Parsippany, NJ. A barcode is also visible.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
